Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Post by
Whalewatcher1
on Nov 22, 2023 9:48am
Algernon announces acquisition of chronic cough program
So what's the real story here? Program acquired by US based Seylyx Inc. they have a barebone website and the domain was registered nov 16 2023. There's no people associated with this company
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Nov 13, 2023 1:14pm
Today’s Trading
Nothing doing, then, out of the clear blue - a trade for an eye-watering $130 that knocks $147,000 off shareholder value!! the kids in the sandbox never seem to get tired of the game
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Nov 01, 2023 3:46pm
Today’s Trading
Looking at today's bid/ask board- Integral is nowhere to be seen. Never mind! There has been a trade, with a value of $70 that brought the market price down to $0.07. It involved National Bank.&
...more
(191)
•••
EricSnott
X
View Profile
View Bullboard History
Post by
EricSnott
on Oct 27, 2023 1:32pm
Is this one still trading??? Bunch of crooks here!!
eom
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Aug 22, 2023 2:42pm
And they call this a market?
Down one and a half cents today solely on a couple of mini trades. National Band the buyer and seller!
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Aug 09, 2023 7:08pm
RE:RE:Phase 2 DMT Stroke Study Design Finalized
This company needs new management. A reset on strategy, pick an indication and finally run a properly designed trial. Seemed they had positive trend data for chronic cough. Chris keeps using Bellus as
...more
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Aug 09, 2023 7:04pm
RE:Phase 2 DMT Stroke Study Design Finalized
Nice post, but do you really think they can raise the $4-5m to run such trial with market cap below $2M and raise $200k to cover maybe a month of burn. even if they figured out a way to
...more
(127)
•••
SkywalkerofLuke
X
View Profile
View Bullboard History
Post by
SkywalkerofLuke
on Aug 08, 2023 3:32pm
Phase 2 DMT Stroke Study Design Finalized
Following encouraging results from AGN.c AGNPF’s Phase 1 study of DMT for stroke treatment, AGN is now advancing and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study.
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jul 28, 2023 5:40pm
And they call this a market?
Price dropped half a cent and stayed there by way of 4 mini trades from - Integral and National Bank with a total expenditure of $800. Wow! It brings to mind an old Chinese saying "In shallow
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jul 26, 2023 11:28am
Today’s trading
Ditto! Same as yesterday. Two mini trades same buyers - same selling source. in this a marker?
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jul 25, 2023 12:17pm
Today’s Trading
Here we go again . no trading except two mini trades dropping the price to 20 cents, And who are the buyers? Integral and National Bank! Again. And the seller? Someone with Scotia Capital. Again! It
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 14, 2023 6:00pm
New Press Release - Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”), a Canadian clinical stage pharmaceutical development company, announces a non-brokered private placement for gross proceeds of...
read article.
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Post by
Whalewatcher1
on Jul 07, 2023 6:29pm
What’s going on here?
Things gone very quite . . . Where's all the marketing budget to talk up the stock (as per financial statements)? So they spin out the stroke program into new company, called Algernon neuroscience
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jul 06, 2023 2:45pm
Trading Today
They're still at it. I must say I would feel happier if there were a regulator around to keep an eye on things
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jul 06, 2023 2:38pm
Recent Trading
The recent good news from Algernon drove the price up to 25 cents. Shortly after, the price started dropping by way of mini trades between Integral and National Bank. Seems odd!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >